Epidiolex

Zogenix: Could This Be The Greatest Threat to GW Pharmaceuticals?
Zogenix: Could This Be The Greatest Threat to GW Pharmaceuticals?
Motley Fool
Zogenix
GW Pharma
Sativex
Epidiolex
LGS
Dravet syndrome
Flag link:
GW Pharmaceuticals’ Cannabis Drug Show Promise in Late-Stage Clinical Trial of Epilepsy
GW Pharmaceuticals’ Cannabis Drug Show Promise in Late-Stage Clinical Trial of Epilepsy
Xtalks
GW Pharma
cannabis
clinical trials
Epidiolex
epilepsy
Dravet syndrome
Flag link:
3 Reasons GW Pharmaceuticals Stock Could Rise
3 Reasons GW Pharmaceuticals Stock Could Rise
Motley Fool
GW Pharma
Epidiolex
Flag link:
3 for 3 in PhIII: GW Pharma racing to the FDA after bagging another late-stage epilepsy success
3 for 3 in PhIII: GW Pharma racing to the FDA after bagging another late-stage epilepsy success
Endpoints
GW Pharma
FDA
Epidiolex
epilepsy
Flag link:
GW Pharma to raise $252 mln after cannabis drug success
GW Pharma to raise $252 mln after cannabis drug success
Yahoo/Reuters
GW Pharma
marijuana
Epidiolex
Flag link:
5 Major Clinical Trial Results Coming Up
5 Major Clinical Trial Results Coming Up
24/7 Wall St
clinical trials
Vertex Pharmaceuticals
Orkambi
Puma Biotechnology
neratinib
GW Pharma
Epidiolex
Agios Pharmaceuticals
AG-348
AG-519
Dermira
DRM-04
Flag link:
8 Major Biopharma Events Coming Later in 2016 and in 2017
8 Major Biopharma Events Coming Later in 2016 and in 2017
24/7 Wall St
Vertex Pharmaceuticals
VX-661
cystic fibrosis
Incyte
ruxolitinib
colorectal cancer
breast cancer
Ultragenyx
KRN23
osteomalacia
GW Pharma
Epidiolex
Puma Biotechnology
neratinib
Celator Pharmaceuticals
Vyxeos
Biocryst
OPuS-2
BCX7353
HAE
Galena Biopharma
NeuVax
trastuzumab
Flag link:
GW Pharmaceuticals' Marijuana-Based Drug Hits the Mark in Pivotal-Stage Study
GW Pharmaceuticals' Marijuana-Based Drug Hits the Mark in Pivotal-Stage Study
Motley Fool
GW Pharma
marijuana
epilepsy
anti-seizure
Epidiolex
Flag link:
GW Pharma CEO jumps to the U.S., betting on epilepsy approval
GW Pharma CEO jumps to the U.S., betting on epilepsy approval
Fierce Biotech
GW Pharma
epilepsy
cannabis
Justin Gover
Epidiolex
Flag link:
GW Pharma's cannabis-based epilepsy drug cuts seizure rates by 50%
GW Pharma's cannabis-based epilepsy drug cuts seizure rates by 50%
BioPharma Dive
GW Pharma
epilepsy
cannabis
Epidiolex
Flag link:
GW Pharma rises after analyst sees promise in marijuana-derived epilepsy drug
GW Pharma rises after analyst sees promise in marijuana-derived epilepsy drug
The Fly on the Wall
GW Pharma
epilpesy
marijuana
Epidiolex
Flag link:
GW Pharma Up On Positive Data For Epilepsy Drug
GW Pharma Up On Positive Data For Epilepsy Drug
Investors.com
epilepsy
GW Pharma
Epidiolex
Flag link:
GW Pharma receives FDA fast-track designation for Dravet syndrome treatment
GW Pharma receives FDA fast-track designation for Dravet syndrome treatment
Reuters
FDA
GW Pharma
fast track
Dravet syndrome
Epidiolex
Flag link:
FDA approves GW drug trial
FDA approves GW drug trial
Yahoo/Investors Business Daily
FDA
GW Pharma
Epidiolex
Flag link: